Browse Category

Stock Market News 27 January 2026

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 27.01.2026

5N Plus Inc. shares have surged over 1,200% in a decade, while Brookfield Infrastructure Partners trades near $48.35, up from $20 ten years ago. PROCEPT BioRobotics rose 3.95% in one day but remains down 57.81% year-over-year. Micron Technology posted 57% cloud revenue growth and trades at a forward P/E of 11.6. India’s Sensex jumped nearly 600 points to 82,451 on trade deal optimism.
27 January 2026
Bloom Energy stock drops as Jefferies lifts target but stays bearish ahead of Feb. 5 results

Bloom Energy stock drops as Jefferies lifts target but stays bearish ahead of Feb. 5 results

Bloom Energy shares fell 3.7% to $139.62 Monday, underperforming the S&P 500’s 0.5% gain. Jefferies raised its price target to $92 but kept an Underperform rating, warning expectations are high. Investors await Bloom’s Feb. 5 results for updates on 2026 deployments and margins. Other fuel-cell stocks, including Plug Power and FuelCell Energy, also dropped.
Citigroup stock edges higher as harassment lawsuit hits headlines ahead of Fed meeting

Citigroup stock edges higher as harassment lawsuit hits headlines ahead of Fed meeting

Citigroup shares closed up 0.9% at $114.65 Monday, edging higher after hours despite news of a lawsuit alleging mishandled sexual harassment claims by a former managing director. The suit names Andy Sieg, head of Citi’s wealth division; Citi called the allegations “absolutely meritless.” The stock’s move tracked gains in other major banks ahead of a key Federal Reserve meeting starting Tuesday.
27 January 2026
Uber stock slips as NYC forces 10% tip prompt on Uber Eats orders; focus turns to Feb. 4 earnings

Uber stock slips as NYC forces 10% tip prompt on Uber Eats orders; focus turns to Feb. 4 earnings

Uber shares fell 0.4% to $81.98 Monday after New York City’s new tipping rules for delivery apps took effect. DoorDash, Uber, and Instacart failed to block the regulations in court and plan to appeal. The rules require a tip prompt at checkout and ban hidden or delayed tipping options. Investors await Uber’s Feb. 4 earnings for signs of regulatory impact on delivery demand and costs.
Gilead (GILD) stock hits fresh 52-week high as new analyst targets and CEO sale filing land

Gilead (GILD) stock hits fresh 52-week high as new analyst targets and CEO sale filing land

Gilead Sciences shares closed at a 52-week high of $137.78 on Monday, up 1.36% for a fourth straight gain. CEO Daniel O’Day sold $15.6 million in stock under a pre-set plan, according to an SEC filing. BMO and UBS raised their price targets, citing momentum in HIV drugs and new coverage for Yeztugo. Trading volume exceeded normal levels as the stock outperformed major pharma peers.
Meta stock pops on a fresh $900 bull call as earnings near — here’s what investors are watching

Meta stock pops on a fresh $900 bull call as earnings near — here’s what investors are watching

Meta shares rose about 2% Monday after Rothschild & Co Redburn upgraded the stock to “buy” and raised its price target to $900 ahead of earnings. Bank of America kept its buy rating and $810 target, projecting Meta will top Q4 estimates. Investors are focusing on Meta’s 2026 AI spending guidance, with capital expenditures expected to reach $117 billion. Meta reports results after Wednesday’s close.
AbbVie stock price closes higher; what to watch next for ABBV ahead of Fed week and earnings

AbbVie stock price closes higher; what to watch next for ABBV ahead of Fed week and earnings

AbbVie shares closed up 0.7% at $220.77 on Monday, moving with broader Wall Street gains ahead of the Federal Reserve’s policy decision and major tech earnings. The company will report full-year and Q4 results before the market opens on Feb. 4. AbbVie recently signed a $650 million cancer drug licensing deal with RemeGen and faces investor scrutiny over its post-Humira growth strategy.
Zoom stock jumps as Baird spots a “hidden gem” Anthropic stake worth up to $4 billion

Zoom stock jumps as Baird spots a “hidden gem” Anthropic stake worth up to $4 billion

Zoom shares rose about 11% Monday after a Baird analyst estimated the company’s early stake in Anthropic could be worth $2 billion to $4 billion if the AI startup reaches a $350 billion valuation. Zoom previously disclosed spending $51 million on private equity investments in early 2023 but has not detailed its Anthropic holdings.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
New York, Feb 7, 2026, 17:36 EST — Market closed. Walt Disney shares rose 3.6% on Friday to close at $108.70, trimming the damage from an early-week slide as U.S. stocks snapped back into risk-on mode. (Yahoo Finance) With U.S. markets shut for the weekend, the next session opens with Disney caught between two big forces: a market that is suddenly willing to buy again, and a media business that is still being rewired in public. For Disney, that matters now because its most visible growth levers — streaming and experiences — move on sentiment as much as on the
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop